Exodus Point Capital Management, LP 4 D Molecular Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$20.93 - $30.01 $1.05 Million - $1.5 Million	49,945 New	49,945 $1.05 Million
Q3 2023 Nov 09, 2023	BUY	$12.64 - $19.76 $370,440 - $579,106	29,307 New	29,307 $373,000
Q1 2021 May 17, 2021	SELL	$35.94 - $52.67 $1.19 Million - $1.75 Million	-33,152 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$38.43 - $47.36 $1.27 Million - $1.57 Million	33,152 New	33,152 $1.37 Million

144

57.7M

137K

111K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $272M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.